Radiofrequency Ablation in Patients With Primary and Secondary Hepatic Malignancies

Journal of Gastrointestinal Surgery

Volumn 10, Issue 7, 2006, Pages 960-973

  de Meijer, V E ^a   Verhoef, C ^a   Kuiper, J W ^a   Alwayn, I P J ^a   Kazemier, G ^a   IJzermans, J N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Liver cancer; local tumor progression; radiofrequency ablation

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CATHETER ABLATION; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33745945849     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2006.03.003     Document Type: Article

References (52)

1. Levi F., Lucchini F., Negri E., Boyle P., and La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 110 2 (2004) 155-169
2. Visser O, Siesling S, van Dijck JAAM. Incidence of cancer in the Netherlands 1999/2000. Available at: http://www.ikcnet.nl. Accessed April 24, 2005.
3. Stangl R., Altendorf-Hofmann A., Charnley R.M., and Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 343 (1994) 1405-1410
4. Scheele J. Hepatectomy for liver metastases. Br J Surg 80 (1993) 274-276
5. Bruinvels D.J., Stiggelbout A.M., Kievit J., van Houwelingen H.C., Habbema J.D., and van de Velde C.J. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219 (1994) 174-182
6. Cady B., Jenkins R.L., Steele Jr. G.D., et al. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg 227 (1998) 566-571
7. Taylor-Robinson S.D., Foster G.R., Arora S., Hargreaves S., and Thomas H.C. Increase in primary liver cancer in the UK, 1979-94. Lancet 350 (1997) 1142-1143
8. Deuffic S., Poynard T., Buffat L., and Valleron A.J. Trends in primary liver cancer. Lancet 351 (1998) 214-215
9. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
10. Verhoef C., Visser O., de Man R.A., de Wilt J.H., IJzermans J.N.M., and Janssen-Heijnen M.L. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Eur J Cancer 40 (2004) 1530-1538
11. Fong Y., Sun R.L., Jarnagin W., and Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 (1999) 790-799
12. Colella G., Bottelli R., De Carlis L., et al. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 11 Suppl 1 (1998) S193-S196
13. van Etten B., Brunstein F., van I.M.G., et al. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: A phase I and II study. Ann Surg Oncol 11 (2004) 598-605
14. Verhoef C., Kuiper J.W., Heisterkamp J., de Man R.A., Pattynama P.M., and IJzermans J.N.M. Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma. Br J Surg 90 (2003) 950-955
15. Kaplan E.S., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
16. Cox D.R. Regression models and life tables. J R Stat Soc B34 (1972) 187-220
17. Bleicher R.J., Allegra D.P., Nora D.T., Wood T.F., Foshag L.J., and Bilchik A.J. Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol 10 (2003) 52-58
18. de Baere T., Elias D., Dromain C., et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175 (2000) 1619-1625
19. Jiang H.C., Liu L.X., Piao D.X., et al. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 8 (2002) 624-630
20. Pawlik T.M., Izzo F., Cohen D.S., Morris J.S., and Curley S.A. Combined resection and radiofrequency ablation for advanced hepatic malignancies: Results in 172 patients. Ann Surg Oncol 10 (2003) 1059-1069
21. Siperstein A., Garland A., Engle K., et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 7 (2000) 106-113
22. Tepel J., Hinz S., Klomp H.J., Kapischke M., and Kremer B. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies. Eur J Surg Oncol 30 (2004) 551-555
23. Wong S.L., Edwards M.J., Chao C., Simpson D., and McMasters K.M. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg 182 (2001) 552-557
24. Wood T.F., Rose D.M., Chung M., Allegra D.P., Foshag L.J., and Bilchik A.J. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 7 (2000) 593-600
25. Bowles B.J., Machi J., Limm W.M., et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 136 (2001) 864-869
26. Kosari K., Gomes M., Hunter D., Hess D.J., Greeno E., and Sielaff T.D. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg 6 (2002) 255-263
27. Buscarini L., Buscarini E., Di Stasi M., Vallisa D., Quaretti P., and Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 11 (2001) 914-921
28. Curley S.A., Izzo F., Ellis L.M., Nicolas Vauthey J., and Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232 (2000) 381-391
29. Giovannini M., Moutardier V., Danisi C., Bories E., Pesenti C., and Delpero J.R. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: Results and outcomes in 56 patients. J Gastrointest Surg 7 (2003) 791-796
30. Harrison L.E., Koneru B., Baramipour P., et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 197 (2003) 759-764
31. Lam C.M., Ng K.K., Poon R.T., Ai V., Yuen J., and Fan S.T. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 91 (2004) 334-338
32. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103 (2005) 1201-1209
33. Vivarelli M., Guglielmi A., Ruzzenente A., et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240 (2004) 102-107
34. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
35. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127 (2004) 1714-1723
36. Choi D., Lim H.K., Kim M.J., et al. Recurrent hepatocellular carcinoma: Percutaneous radiofrequency ablation after hepatectomy. Radiology 230 (2004) 135-141
37. Guglielmi A., Ruzzenente A., Battocchia A., Tonon A., Fracastoro G., and Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 50 (2003) 480-484
38. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology 214 (2000) 761-768
39. Xu H.X., Xie X.Y., Lu M.D., et al. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 59 (2004) 53-61
40. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825
41. Gillams A.R., and Lees W.R. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14 (2004) 2261-2267
42. Livraghi T., Solbiati L., Meloni F., Ierace T., Goldberg S.N., and Gazelle G.S. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The "test-of-time approach". Cancer 97 (2003) 3027-3035
43. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 221 (2001) 159-166
44. White T.J., Roy-Choudhury S.H., Breen D.J., et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 21 (2004) 314-320
45. Goldstein M.J., and Peterson Mitchell E. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23 (2005) 338-351
46. Yuen M.-F., and Lai C.-L. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 19 (2005) 91-99
47. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240 (2004) 644-657
48. Oshowo A., Gillams A., Harrison E., Lees W.R., and Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90 (2003) 1240-1243
49. Cheng J., Glasgow R.E., O'Rourke R.W., Swanstrom L.L., and Hansen P.D. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc 17 (2003) 61-67
50. Curley S.A., Marra P., Beaty K., et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239 (2004) 450-458
51. Mulier S., Mulier P., Ni Y., et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 89 (2002) 1206-1222
52. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria. Radiology 235 (2005) 728-739